Business / Finance

RSS

CRH acquires assets of Physicians Immediate Med

CRH Healthcare, a quality- and patient-focused operator of urgent care centers in Alabama and Georgia recently acquired the assets of Physicians Immediate Med, the leading urgent care and family care platform in Atlanta.

25 Aug 2015

ulrich medical USA plans to increase workforce to meet the growing demands of spine implant business

ulrich medical USA, Inc. today announced plans to significantly increase its U.S. workforce in order to accommodate for the increasing demands of its dynamic spine implant business. Fueled by four consecutive years of profitable, double-digit growth and twenty percent year-to-date growth, the company is investing in its future and expanding across multiple functional areas within North America.

25 Aug 2015

Accutest makes strategic expansion into Latin America to support the growth of pharmaceutical sector

Accutest Research Laboratories, a leading global Contract Research Organization (CRO), further pursues its strategic expansion into Latin America by opening offices and establishing operational presence in Brazil.

25 Aug 2015

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec Biopharma Limited, a clinical-stage biotechnology company, is pleased to announce the closing of its U.S. initial public offering of 1,500,000 American Depositary Shares (ADSs), representing 30,000,000 fully paid ordinary shares of Benitec, together with warrants to purchase 500,000 ADSs, representing 10,000,000 fully paid ordinary shares.

24 Aug 2015

Esperance, MD Anderson form strategic alliance to accelerate development of anti-cancer candidate EP-100

Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer candidate EP-100 for the treatment of ovarian cancer and to collaborate on preclinical studies of EP-100 as a treatment for breast cancer.

24 Aug 2015

UPMC WorkPartners receives A-rating from A.M. Best

UPMC WorkPartners has retained its financial strength rating of A- (Excellent) from A.M. Best, the world's oldest and most authoritative insurance rating and information source.

24 Aug 2015

DST Systems completes acquisition of Wealth Management Systems

DST Systems, Inc., a global provider of strategically unified data management, business processing, and customer communication solutions, today announced it has completed the previously announced acquisition of retirement plan rollover specialist Wealth Management Systems Inc.

23 Aug 2015

Janus collaborates with Roche to develop TLR inhibitor to address several autoimmune diseases

Janus Biotherapeutics today announced that they have entered into a collaboration with Roche for the development of a small molecule toll-like receptor (TLR) inhibitor with the potential to address several autoimmune diseases. TLRs are an important class of proteins that play a key role in the innate immune system.

20 Aug 2015

PharmaMar to market and distribute APLIDIN drug candidate in Australia, New Zealand

PharmaMar has entered into an exclusive license and commercialization agreement with the pharmaceutical company Specialised Therapeutics Australia Pty (STA) to market and distribute the drug candidate APLIDIN (plitidepsin) in Australia and New Zealand.

20 Aug 2015

DelMar closes on $2.6 million registered direct placement

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced the closing of a registered direct placement (Placement) with $2.6 million received from the offering.

20 Aug 2015

STA inks license and commercialisation agreement with PharmaMar for APLIDIN (plitidepsin)

Australian biopharmaceutical company Specialised Therapeutics Australia has struck an exclusive license and commercialisation agreement with European pharmaceutical partner company PharmaMar to market and distribute the novel oncology drug APLIDIN (plitidepsin) in Australia and New Zealand.

20 Aug 2015

Cyberonics, Sorin provide update on pending business combination

Cyberonics, Inc. and Sorin S.p.A. today announced an update on various matters relating to their pending business combination (the "Transaction").

20 Aug 2015

Cyberonics reports record worldwide net sales of $81.0 million for first fiscal quarter 2016

Cyberonics, Inc. today announced results for the quarter ended July 24, 2015.

20 Aug 2015

Valeant enters into definitive agreement to acquire Sprout Pharmaceuticals

Valeant Pharmaceuticals International, Inc. and Sprout Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a wholly-owned subsidiary of Valeant will acquire Sprout, on a debt-free basis, for approximately $1 billion in cash, plus a share of future profits based upon the achievement of certain milestones.

20 Aug 2015

Equashield reports record revenue growth, expands production facilities for future growth

Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for safe and simple handling of hazardous drugs, today announced a more than doubling of year-over-year revenue.

19 Aug 2015

Telesta closes US$28.6 million in private placement financing

Telesta Therapeutics Inc. announced today that it has closed a private placement financing of US$28.6 million. This transaction was led by several prominent U.S. healthcare investors, including Consonance Capital Investors, Boxer Capital of Tavistock Life Sciences and Omega Funds. In addition, certain members of the senior management team and board of directors of Telesta participated in the transaction.

19 Aug 2015

Bionik Laboratories begins share trading on OTCQX under existing ticker symbol BNKL

Bionik Laboratories Corp., a pioneering medical device and robotics company with a focus in developing transformational technologies and solutions for individuals with neurological disorders, announced that shares of the Company's common stock will begin trading today on the OTCQX® Best Market under its existing ticker symbol "BNKL."

19 Aug 2015

Applying a top restaurant model to healthcare communications: an interview with Brandi Robinson, Sanofi

Communications professionals often are expected to be experts in all facets of the vast spectrum of communications, from brand, corporate, crisis and digital communications to corporate reputation and channel strategy and everything in between.

From Sanofi 19 Aug 2015

Pittcon will be exhibiting at Recent Advances in Microbiology Research: A BioConference Live 2015 Virtual Event

The field of microbiology, the study of minute organisms such as bacteria, viruses, archaea, and eukaryotes, is yielding startling new findings about their effects on people and the environment. Keeping current with these advances while keeping up with a demanding workflow can be challenging.

18 Aug 2015

Quest Diagnostics announces quarterly cash dividend of $0.38 per share

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.38 per share, payable on October 21, 2015 to shareholders of record of Quest Diagnostics common stock on October 6, 2015.

From Quest Diagnostics 18 Aug 2015

Business / Finance

CRH acquires assets of Physicians Immediate Med

ulrich medical USA plans to increase workforce to meet the growing demands of spine implant business

Accutest makes strategic expansion into Latin America to support the growth of pharmaceutical sector

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Esperance, MD Anderson form strategic alliance to accelerate development of anti-cancer candidate EP-100

UPMC WorkPartners receives A-rating from A.M. Best

DST Systems completes acquisition of Wealth Management Systems

Janus collaborates with Roche to develop TLR inhibitor to address several autoimmune diseases

PharmaMar to market and distribute APLIDIN drug candidate in Australia, New Zealand

DelMar closes on $2.6 million registered direct placement

STA inks license and commercialisation agreement with PharmaMar for APLIDIN (plitidepsin)

Cyberonics, Sorin provide update on pending business combination

Cyberonics reports record worldwide net sales of $81.0 million for first fiscal quarter 2016

Valeant enters into definitive agreement to acquire Sprout Pharmaceuticals

Equashield reports record revenue growth, expands production facilities for future growth

Telesta closes US$28.6 million in private placement financing

Bionik Laboratories begins share trading on OTCQX under existing ticker symbol BNKL

Applying a top restaurant model to healthcare communications: an interview with Brandi Robinson, Sanofi

Pittcon will be exhibiting at Recent Advances in Microbiology Research: A BioConference Live 2015 Virtual Event

Quest Diagnostics announces quarterly cash dividend of $0.38 per share

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Latest News